Immunotherapy has emerged as an effective strategy for the prevention and treatment of a
variety of diseases, including cancer, infectious diseases, inflammatory diseases, and …

Although the complexity of synthetic cells has continued to increase in recent years,
chemical communication between protocell models and living organisms remains a key …

The design of nanovaccines capable of triggering effective antitumor immunity requires an
understanding of how the immune system senses and responds to threats, including …

Breakthroughs in materials engineering have accelerated the progress of immunotherapy in
preclinical studies. The interplay of chemistry and materials has resulted in improved …

Cytotoxic CD8 T cells are key effectors in the immunotherapy of malignant and viral
diseases. However, the lack of efficient methods for their in vitro priming and expansion has …

Adoptive immunotherapy—the isolation of antigen-specific cells, their ex vivo expansion and
activation, and subsequent autologous administration—is a promising approach to inducing …

The transduction of primary T cells to express chimeric T cell receptors (cTCR) for redirected
targeting of tumor cells is an attractive strategy for generating tumor-specific T cells for …